ATE264098T1 - Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen - Google Patents

Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen

Info

Publication number
ATE264098T1
ATE264098T1 AT99968461T AT99968461T ATE264098T1 AT E264098 T1 ATE264098 T1 AT E264098T1 AT 99968461 T AT99968461 T AT 99968461T AT 99968461 T AT99968461 T AT 99968461T AT E264098 T1 ATE264098 T1 AT E264098T1
Authority
AT
Austria
Prior art keywords
drug
patch
volatile
active ingredients
liquid active
Prior art date
Application number
AT99968461T
Other languages
German (de)
English (en)
Inventor
J Miranda
C J Ii Betlach
Original Assignee
Elan Pharma Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22337613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE264098(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elan Pharma Int Ltd filed Critical Elan Pharma Int Ltd
Application granted granted Critical
Publication of ATE264098T1 publication Critical patent/ATE264098T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99968461T 1998-12-07 1999-12-07 Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen ATE264098T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11128598P 1998-12-07 1998-12-07
PCT/US1999/028697 WO2000033812A2 (en) 1998-12-07 1999-12-07 Transdermal patch for delivering volatile liquid drugs

Publications (1)

Publication Number Publication Date
ATE264098T1 true ATE264098T1 (de) 2004-04-15

Family

ID=22337613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99968461T ATE264098T1 (de) 1998-12-07 1999-12-07 Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen

Country Status (9)

Country Link
EP (1) EP1137406B2 (enExample)
JP (1) JP2002531488A (enExample)
KR (1) KR100885235B1 (enExample)
AT (1) ATE264098T1 (enExample)
AU (1) AU778992B2 (enExample)
CA (1) CA2380391A1 (enExample)
DE (1) DE69916492T3 (enExample)
NZ (2) NZ525878A (enExample)
WO (1) WO2000033812A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797276B1 (en) 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
WO2000041538A2 (en) 1999-01-14 2000-07-20 Noven Pharmaceuticals, Inc. Dermal compositions
JP2005504002A (ja) 2001-02-13 2005-02-10 ガバメント オブ ザ ユナイテッド ステイツ、 アズ リプリゼンティッド バイ ザ セクレタリィ オブ ジ アーミイ 経皮免疫感作のためのワクチン
DE10110391A1 (de) 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
CN1516595A (zh) * 2001-03-19 2004-07-28 Iomai公司 用于经皮免疫的贴剂
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
US20040086551A1 (en) 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
CA2518385A1 (en) * 2003-03-14 2004-09-23 Agi Therapeutics Ltd. Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine
US20070224284A1 (en) 2004-03-12 2007-09-27 John Devane Methods and compositions comprising at least one alpha3 beta4 nAChR antagonist or pharmaceutically acceptable salt thereof
WO2005025549A2 (en) 2003-09-10 2005-03-24 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
JP2007509951A (ja) * 2003-10-28 2007-04-19 ノーヴェン ファーマシューティカルズ インコーポレイテッド 経皮的なドラッグデリバリーシステムにおける医薬品の損失及び送達を制御するための組成物及び方法
ITMI20041697A1 (it) * 2004-09-03 2004-12-03 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico in forma di cerotto multistrato
US8343538B2 (en) 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
WO2006041911A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Device transdermal administration of drugs including acrylic polymers
IL177071A0 (en) 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
ES2499067T3 (es) 2005-10-13 2014-09-26 Nitto Denko Corporation Preparación transdérmica de nicotina y método de producción de la misma
DE102006054733A1 (de) 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
CN102164601A (zh) * 2008-09-30 2011-08-24 帝国制药美国公司 经皮延长给药多奈哌齐组合物及其使用方法
EP2298277A1 (en) * 2009-09-09 2011-03-23 Labtec GmbH Transdermal patch formulation
US9017723B2 (en) 2010-04-30 2015-04-28 Teikoku Pharma Usa, Inc. Propynylaminoindan transdermal compositions
WO2012129429A2 (en) 2011-03-24 2012-09-27 Teikoku Pharma Usa, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
WO2013070526A1 (en) 2011-11-09 2013-05-16 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
NZ706590A (en) 2012-11-02 2016-02-26 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
DE102013013397A1 (de) 2013-08-13 2015-03-12 Epinamics Gmbh Aerosolspender für transdermal wirkende pharmazeutische Zusammensetzungen
DE102013020633A1 (de) 2013-12-16 2015-06-18 Epinamics Gmbh Dermale und/oder transdermale pharmazeutische Zusammensetzung enthaltend eine terpenoide Verbindung
DE102020112143B4 (de) 2020-05-05 2022-03-17 Lts Lohmann Therapie-Systeme Ag Nicotin - Corona

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717568A (en) * 1985-08-09 1988-01-05 Alza Corporation Laminar arrangement for increasing delivery of beneficial agent from dispenser
US5316759A (en) † 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
DE3629304A1 (de) † 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
CH674618A5 (enExample) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB8807504D0 (en) † 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
DE3908432A1 (de) * 1989-03-14 1990-09-27 Lohmann Therapie Syst Lts Pflaster als therapeutisches system zur verabreichung von wirkstoffen an die haut mit einer abgestuften wirkstoffabgabe, verfahren zu seiner herstellung sowie verwendung
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
JPH09505028A (ja) † 1993-07-09 1997-05-20 シグナス，インコーポレイテッド 経皮的／経頬的にニコチン置換治療を提供する方法およびデバイス
DE4332094C2 (de) † 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
JP3021661B2 (ja) * 1994-03-07 2000-03-15 セラテック・インコーポレーテッド 薬剤含有接着複合体の経皮放出デバイス
IL122484A0 (en) * 1995-06-07 1998-06-15 Noven Pharma Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US5691365A (en) * 1995-07-18 1997-11-25 University Of Kentucky Research Foundation Nicotinic receptor antagonists in the treatment of neuropharmacological disorders
JPH09301853A (ja) * 1996-05-14 1997-11-25 Nitto Denko Corp 貼付剤および貼付製剤

Also Published As

Publication number Publication date
AU2587700A (en) 2000-06-26
WO2000033812A3 (en) 2000-11-23
EP1137406B1 (en) 2004-04-14
EP1137406A2 (en) 2001-10-04
EP1137406B2 (en) 2008-01-23
WO2000033812A2 (en) 2000-06-15
DE69916492T2 (de) 2005-05-12
NZ512788A (en) 2003-07-25
JP2002531488A (ja) 2002-09-24
CA2380391A1 (en) 2000-06-15
KR100885235B1 (ko) 2009-02-24
NZ525878A (en) 2004-12-24
DE69916492T3 (de) 2008-08-14
KR20010101147A (ko) 2001-11-14
DE69916492D1 (de) 2004-05-19
AU778992B2 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
ATE264098T1 (de) Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen
US5846559A (en) Skin patch for use in contact immunotherapy
KR960703545A (ko) 테스토스테론의 공급을 위한 피부패치 및 방법(skin patches and methods for providing testosterone)
ATE122899T1 (de) Verfahren und gegenstand zur transdermalen administration von dexmedetomidin.
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
KR910009264A (ko) 2-아미노-6-n-프로필아미노-4,5,6,7-테트라하이드로벤조티아졸의 경피 투여
JP2002531488A5 (enExample)
DE59410103D1 (de) Transdermales therapeutisches system mit galanthamin als wirksamen bestandteil
DE69531488D1 (de) Medikament enthaltende, adhesive, zusammenbaubare, transdermale abgabevorrichtung
JPS63501075A (ja) ベラパミルの経皮供給用デバイス
ATE5563T1 (de) Therapeutisches system zum zufuehren von arzneimitteln zur haut.
NO20001003L (no) Transdermalt terapeutisk system omfattende et trykksensitivt adhesivt reservoarsjikt og et unidireksjonalt elastisk dekksjikt
DE69332066D1 (de) Pflaster zur transdermalen verabreichung eines medikaments
DE69923348D1 (de) Transdermales arzneistoffverabreichungssystem
Czech et al. Acrylic pressure‐sensitive adhesive for transdermal drug delivery systems
NZ509215A (en) Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels
ATE354357T1 (de) Transdermales therapeutisches system enthaltend leich flüchtige wirkstoffe
EP1449527A3 (en) Transdermal patch for administering a volatile liquid drug
DE50100870D1 (de) Transdermales therapeutisches system zur verabreichung von zaleplon
ID24266A (id) Sistim terapetik transdermal yang mengandung bahan aktif basa skopolamin
FI952269A0 (fi) Ihonläpäisevä terapeuttinen järjestelmä fysostigmiinin antamiseen iholle ja menetelmä järjestelmän valmistamiseksi
CN221512922U (zh) 一种医用膏药贴
BR112021009956A2 (pt) sistema terapêutico transdérmico, seu uso e seu processo de produção,kit que compreende pelo menos um sistema terapêutico transdérmico
KR19980701419A (ko) (s)-3-메틸-5-(1-메틸-2-피롤리데닐)-이속사졸 또는 약제학적으로 허용가능한 이의 염들 중 하나를 투여하기 위한 트랜스더멀 치료 시스템
JPH08260330A (ja) 不織布及びそれを用いた貼付薬基材

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties